Kees Meijer

811 total citations
16 papers, 646 citations indexed

About

Kees Meijer is a scholar working on Hematology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Kees Meijer has authored 16 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Nutrition and Dietetics. Recurrent topics in Kees Meijer's work include Acute Myeloid Leukemia Research (5 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Kees Meijer is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Kees Meijer collaborates with scholars based in Netherlands and Norway. Kees Meijer's co-authors include Marion G. Priebe, Paul de Vos, Roel J. Vonk, Niels Kloosterhuis, Desirée Weening, Marcel de Vries, Bart‐Jan Kroesen, Martijn Dijkstra, Farhad Rezaee and Saad Al-Lahham and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Kees Meijer

13 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kees Meijer Netherlands	8	262	184	133	101	92	16	646
Rodrigo Aguilera Olvera United States	5	313 1.2×	133 0.7×	125 0.9×	48 0.5×	95 1.0×	7	525
Joshua A. Owens United States	11	592 2.3×	202 1.1×	127 1.0×	97 1.0×	85 0.9×	19	899
Rachel M. Golonka United States	15	504 1.9×	157 0.9×	108 0.8×	136 1.3×	123 1.3×	33	905
Yael Haberman Israel	17	395 1.5×	208 1.1×	134 1.0×	106 1.0×	93 1.0×	44	826
Willem de Villiers United States	8	331 1.3×	305 1.7×	219 1.6×	143 1.4×	84 0.9×	10	724
Yalan Huang China	10	457 1.7×	119 0.6×	108 0.8×	73 0.7×	92 1.0×	22	729
Klara Kostovcikova Czechia	13	346 1.3×	144 0.8×	190 1.4×	114 1.1×	38 0.4×	22	660
Lingyi Wu China	10	402 1.5×	91 0.5×	96 0.7×	61 0.6×	88 1.0×	18	650
Shumin Huang China	11	461 1.8×	142 0.8×	149 1.1×	58 0.6×	59 0.6×	30	815

Countries citing papers authored by Kees Meijer

Since Specialization

Citations

This map shows the geographic impact of Kees Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Meijer more than expected).

Fields of papers citing papers by Kees Meijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Meijer. The network helps show where Kees Meijer may publish in the future.

Co-authorship network of co-authors of Kees Meijer

This figure shows the co-authorship network connecting the top 25 collaborators of Kees Meijer. A scholar is included among the top collaborators of Kees Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees Meijer. Kees Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Meijer, Kees, et al.. (2025). Early ICANS recognition with a novel electroencephalogram-based deltawave detection system in patients receiving CAR T-cell therapy. 1(2). 100006–100006.

Morsink, Linde M., Goda Choi, Marco R. de Groot, et al.. (2025). Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD. Bone Marrow Transplantation. 60(12). 1660–1662.

Meijer, Kees, et al.. (2025). Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis. Cytometry Part A. 107(8). 538–550.

Morsink, Linde M., Goda Choi, Marco R. de Groot, et al.. (2024). Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression. Transplantation and Cellular Therapy. 30(8). 794–807. 4 indexed citations

Pereira‐Martins, Diego A., Dimitrios Kleftogiannis, Albertus T.J. Wierenga, et al.. (2022). Full Spectrum 40-Parameter Single-Tube Flow Cytometry Analysis for Longitudinal Immunophenotyping and Tracing of Clonal Heterogeneity in AML. Blood. 140(Supplement 1). 9140–9141. 1 indexed citations

Meijer, Kees, Linde M. Morsink, Carolien M. Woolthuis, et al.. (2021). CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones. Blood Advances. 6(7). 2129–2143. 7 indexed citations

Morsink, Linde M., Walter J. F. M. van der Velden, André B. Mulder, et al.. (2020). Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy. Transplantation and Cellular Therapy. 27(3). 246–252. 9 indexed citations

Plas, Willemijn Y. van der, Anton F. Engelsman, Akin Özyilmaz, et al.. (2016). Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism. Annals of Surgical Oncology. 24(1). 15–22. 32 indexed citations

Meijer, Kees, Desirée Weening, Marcel P. de Vries, et al.. (2015). Quantitative proteomics analyses of activation states of human THP-1 macrophages. Journal of Proteomics. 128. 164–172. 16 indexed citations

10.

Meijer, Kees, Roel J. Vonk, Marion G. Priebe, & Han Roelofsen. (2014). Cell-based screening assay for anti-inflammatory activity of bioactive compounds. Food Chemistry. 166. 158–164. 15 indexed citations

11.

Meijer, Kees. (2014). Metabolic inflammation: mechanistic views and preventive nutritional strategies. Data Archiving and Networked Services (DANS). 1 indexed citations

12.

Szalowska, Ewa, et al.. (2011). Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight. Peptides. 32(5). 938–945. 21 indexed citations

13.

Meijer, Kees, Marcel de Vries, Saad Al-Lahham, et al.. (2011). Human Primary Adipocytes Exhibit Immune Cell Function: Adipocytes Prime Inflammation Independent of Macrophages. PLoS ONE. 6(3). e17154–e17154. 169 indexed citations

14.

Jansen, Liesbeth, Kees Meijer, Theo M. de Kok, et al.. (2011). Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy. Breast Cancer Research and Treatment. 129(1). 157–164. 9 indexed citations

15.

Vonk, Roel J., Marion G. Priebe, Kees Meijer, Koen Venema, & Han Roelofsen. (2011). The Interaction of Short-Chain Fatty Acids (SCFA) With Adipose Tissue; Relevance for Systemic Inflammation. Gastroenterology. 140(5). S–860. 6 indexed citations

16.

Meijer, Kees, Paul de Vos, & Marion G. Priebe. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?. Current Opinion in Clinical Nutrition & Metabolic Care. 13(6). 715–721. 356 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact